Cate Speake

4.3k citations

73 papers · 1.8k indexed · h-index 26

Impact in

Endocrinology, Diabetes and Metabolism top 2%
- Diabetes Management and Research
Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology

Papers in ⓘ

Genetics 52
- Diabetes and associated disorders 49
Immunology 39
- Immune Cell Function and Interaction 30
- T-cell and B-cell Immunology 12
- Immunotherapy and Immune Responses 4

Co-authors: Carla J. Greenbaum (35 shared papers)Peter S. Linsley (13 shared papers)Elizabeth Whalen (6 shared papers)Damien Chaussabel (6 shared papers)William W. Kwok (10 shared papers)Vivian H. Gersuk (8 shared papers)Matthew J. Dufort (7 shared papers)Hannah A. DeBerg (5 shared papers)
Journals: JCI Insight (8 papers)Diabetes (7 papers)The Journal of Immunology (6 papers)The Journal of Clinical Endocrinology & Metabolism (6 papers)PLoS ONE (6 papers)
Partner nations: United States France Canada

In The Last Decade

Cate Speake

69 papers receiving 1.8k citations

Peers

Countries citing papers authored by Cate Speake

Since Specialization

Citations

This map shows the geographic impact of Cate Speake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cate Speake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cate Speake more than expected).

Fields of papers citing papers by Cate Speake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cate Speake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cate Speake. The network helps show where Cate Speake may publish in the future.

Co-authors

The 25 scholars most cited alongside Cate Speake, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cate Speake Line = papers co-authored together Cate Speake links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A phenotypically and functionally distinct human T _H 2 cell subpopulation is associated with allergic disorders Science Translational Medicine ·Erik Wambre, Véronique Bajzik, Jonathan H. DeLong, Kimberly O’Brien, Quynh‐Anh Nguyen, Cate Speake, Vivian H. Gersuk, Hannah A. DeBerg, Elizabeth Whalen, Chester Ni, Mary Farrington, David Jeong, David Robinson, Peter S. Linsley, Brian P. Vickery, William W. Kwok	2017	275
2	Copy Number Loss of the Interferon Gene Cluster in Melanomas Is Linked to Reduced T Cell Infiltrate and Poor Patient Prognosis PLoS ONE ·Peter S. Linsley, Cate Speake, Elizabeth Whalen, Damien Chaussabel	2014	133
3	Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression Journal of Clinical Investigation ·Alice Wiedeman, Virginia Muir, Mario G. Rosasco, Hannah A. DeBerg, Scott Presnell, Bertrand Haas, Matthew J. Dufort, Cate Speake, Carla J. Greenbaum, Elisavet Serti, Gerald T. Nepom, Gabriele Blahnik, Anna Kus, Eddie A. James, Peter S. Linsley, S. Alice Long	2019	125
4	Single-Cell RNA Sequencing Reveals Expanded Clones of Islet Antigen-Reactive CD4+ T Cells in Peripheral Blood of Subjects with Type 1 Diabetes The Journal of Immunology ·Karen Cerosaletti, Fariba Barahmand-pour-Whitman, Junbao Yang, Hannah A. DeBerg, Matthew J. Dufort, Sara A. Murray, Elisabeth Israelsson, Cate Speake, Vivian H. Gersuk, James A. Eddy, Helena Reijonen, Carla J. Greenbaum, William W. Kwok, Erik Wambre, Martin Prlic, Raphaël Gottardo, Gerald T. Nepom, Peter S. Linsley	2017	65
5	ISPAD Clinical Practice Consensus Guidelines 2022: Stages of type 1 diabetes in children and adolescents Pediatric Diabetes ·Rachel Besser, Kirstine J. Bell, Jennifer Couper, Anette‐G. Ziegler, Diane K. Wherrett, Mikael Knip, Cate Speake, Kristina Casteels, Kimberly A. Driscoll, Laura M. Jacobsen, Maria E. Craig, Michael J. Haller	2022	64
6	Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis Lara D. Veeken ·Noémie Jourde‐Chiche, Elizabeth Whalen, B. Gondouin, Cate Speake, Vivian H. Gersuk, Bertrand Dussol, Stéphane Burtey, Virginia Pascual, Damien Chaussabel, Laurent Chiche	2016	54
7	Standardizing T-Cell Biomarkers in Type 1 Diabetes: Challenges and Recent Advances Diabetes ·Simi Ahmed, Karen Cerosaletti, Eddie A. James, S. Alice Long, Stuart I. Mannering, Cate Speake, Maki Nakayama, Timothy Tree, Bart O. Roep, Kevan C. Herold, Todd M. Brusko	2019	48
8	NETosis-associated serum biomarkers are reduced in type 1 diabetes in association with neutrophil count Clinical & Experimental Immunology ·Juan‐Juan Qin, Shengmiao Fu, Cate Speake, Carla J. Greenbaum, Jared Odegard	2016	41
9	Hybrid Insulin Peptides Are Recognized by Human T Cells in the Context of DRB104:01 Diabetes* ·David Arribas-Layton, Perrin Guyer, Thomas Delong, Mylinh Dang, I‐Ting Chow, Cate Speake, Carla J. Greenbaum, William W. Kwok, Rocky L. Baker, Kathryn Haskins, Eddie A. James	2020	41
10	Characterization of regulatory T cells in obese omental adipose tissue in humans European Journal of Immunology ·Dan Wu, Jonathan M. Han, Xin Yu, Avery J. Lam, Romy E. Hoeppli, Anne M. Pesenacker, Qing Huang, Virginia Chen, Cate Speake, Ekua Yorke, Nam Nguyen, Sharadh Sampath, David Harris, Megan K. Levings	2018	41
11	Advances in Type 1 Diabetes Prediction Using Islet Autoantibodies: Beyond a Simple Count Endocrine Reviews ·Michelle So, Cate Speake, Andrea K. Steck, Markus Lundgren, Peter G. Colman, Jerry P. Palmer, Kevan C. Herold, Carla J. Greenbaum	2021	40
12	Abnormalities in proinsulin processing in islets from individuals with longstanding T1D Translational research ·Emily K. Sims, Farooq Syed, Julius O. Nyalwidhe, Henry T. Bahnson, Leena Haataja, Cate Speake, Margaret A. Morris, Appakalai N. Balamurugan, Raghavendra G. Mirmira, Jerry L. Nadler, Teresa L. Mastracci, Peter Arvan, Carla J. Greenbaum, Carmella Evans‐Molina	2019	39
13	Insulin-Like Growth Factor Dysregulation Both Preceding and Following Type 1 Diabetes Diagnosis Diabetes ·Melanie R. Shapiro, Clive Wasserfall, Sean McGrail, Amanda L. Posgai, Rhonda Bacher, Andrew Muir, Michael J. Haller, Desmond Schatz, Johnna D. Wesley, Matthias von Herrath, William Hagopian, Cate Speake, Mark A. Atkinson, Todd M. Brusko	2019	36
14	Cell type–specific immune phenotypes predict loss of insulin secretion in new-onset type 1 diabetes JCI Insight ·Matthew J. Dufort, Carla J. Greenbaum, Cate Speake, Peter S. Linsley	2019	35
15	Strength in Numbers: Opportunities for Enhancing the Development of Effective Treatments for Type 1 Diabetes—The TrialNet Experience Diabetes ·Carla J. Greenbaum, Cate Speake, Jeffrey P. Krischer, Jane H. Buckner, Peter A. Gottlieb, Desmond Schatz, Kevan C. Herold, Mark A. Atkinson	2018	34
16	An interactive web application for the dissemination of human systems immunology data Journal of Translational Medicine ·Cate Speake, Scott Presnell, Kelly Domico, Brad Zeitner, Anna Bjork, David Anderson, Mike J. Mason, Elizabeth Whalen, Olivia Vargas, Д С Попов, Darawan Rinchai, Noémie Jourde‐Chiche, Laurent Chiche, Charlie Quinn, Damien Chaussabel	2015	34
17	Measurement of Pro-Islet Amyloid Polypeptide (1–48) in Diabetes and Islet Transplants The Journal of Clinical Endocrinology & Metabolism ·Jaques A. Courtade, Agnieszka Klimek‐Abercrombie, Yi‐Chun Chen, Nirja Patel, Phoebe Y. T. Lu, Cate Speake, Paul C. Orban, Behzad Najafian, Graydon S. Meneilly, Carla J. Greenbaum, Garth L. Warnock, Constadina Panagiotopoulos, C. Bruce Verchere	2017	32
18	B lymphocyte alterations accompany abatacept resistance in new-onset type 1 diabetes JCI Insight ·Peter S. Linsley, Carla J. Greenbaum, Cate Speake, S. Alice Long, Matthew J. Dufort	2019	32
19	Low HERV-K(C4) Copy Number Is Associated With Type 1 Diabetes Diabetes ·Mike J. Mason, Cate Speake, Vivian H. Gersuk, Quynh-Anh Nguyen, Kimberly K. O’Brien, Jared Odegard, Jane H. Buckner, Carla J. Greenbaum, Damien Chaussabel, Gerald T. Nepom	2014	32
20	Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR PLoS ONE ·Felipe de Jesus Cortez, David Gebhart, Peter V. Robinson, David Seftel, Narges Pourmandi, Jordan Owyoung, Carolyn R. Bertozzi, Darrell M. Wilson, David M. Maahs, Bruce A. Buckingham, John R. Mills, Matthew M. Roforth, Sean J. Pittock, Andrew McKeon, Kara Page, Wendy A. Wolf, Srinath Sanda, Cate Speake, Carla J. Greenbaum, Cheng‐ting Tsai	2020	30

About Cate Speake

Cate Speake is a scholar working on Genetics, Immunology, Surgery, Endocrinology, Diabetes and Metabolism and Infectious Diseases, having authored 73 papers that have together received 1.8k indexed citations. Recurring topics across this work include Diabetes and associated disorders (49 papers), Pancreatic function and diabetes (34 papers), Immune Cell Function and Interaction (30 papers), Diabetes Management and Research (22 papers), T-cell and B-cell Immunology (12 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Immunotherapy and Immune Responses (4 papers) and Single-cell and spatial transcriptomics (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (553 citations), Immunology (665 citations), Genetics (812 citations), Immunology and Allergy (159 citations) and Surgery (678 citations). Cate Speake has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Carla J. Greenbaum, Peter S. Linsley, Elizabeth Whalen, Damien Chaussabel, William W. Kwok, Vivian H. Gersuk, Matthew J. Dufort, Hannah A. DeBerg, S. Alice Long and Eddie A. James. Their work appears in journals such as JCI Insight, Diabetes, The Journal of Immunology, The Journal of Clinical Endocrinology & Metabolism and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact